SEC Form 4Coverage since Jun 8, 2026
$ABEO insider trading
Over the last 12 months, Abeona Therapeutics insiders reported no purchases and 11 sales totaling $1.7M across SEC Form 4 filings. 9% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $1.7M 11 events
- Events · 12m
- 11 Form 4 filings, grouped
- Insiders · 12m
- 6 distinct reporters
- 10b5-1 share
- 9% pre-arranged plans
Side
Price · $ABEO · 12Mvia TradingView
Top insiders · 12m
Vazzano Joseph WalterChief Financial Officer3× · $448K
Vasanthavada MadhavChief Commercial Officer2× · $139K
O'Malley Brendan M.SVP, Chief Legal Officer2× · $144K
Seshadri VishwasChief Executive Officer2× · $775K
Alland Leila—1× · $65K
All insider trades
11 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | Vazzano Joseph WalterChief Financial Officer · O | ▼ Sale | 1,478 | $6.53 | $10K | -0.3% | — |
| Jul 9, 2026 | Vazzano Joseph WalterChief Financial Officer · O | ▼ Sale | 24,880 | $6.96 | $173K | -4.8% | — |
| Jul 9, 2026 | Seshadri VishwasChief Executive Officer · O·D | ▼ Sale | 67,971 | $6.96 | $473K | -4.9% | — |
| Jul 9, 2026 | O'Malley Brendan M.SVP, Chief Legal Officer · O | ▼ Sale | 12,050 | $6.96 | $84K | -2.7% | — |
| Jul 9, 2026 | Vasanthavada MadhavChief Commercial Officer · O | ▼ Sale | 12,606 | $6.96 | $88K | -4.2% | — |
| Jun 30, 2026 | Alland LeilaD | ▼ Sale | 11,000 | $5.92 | $65K | -6.3% | — |
| Jun 15, 2026 | Silverstein Christine BerniD | ▼ Sale | 18,160 | $5.71 | $104K | -13.2% | — |
| Jun 9, 2026 | O'Malley Brendan M.SVP, Chief Legal Officer · O | ▼ Sale | 11,131 | $5.36 | $60K | -2.5% | 2 tranches |
| Jun 9, 2026 | Vazzano Joseph WalterChief Financial Officer · O | ▼ Sale | 49,338 | $5.38 | $265K | -8.7% | plan · 3 tranches |
| Jun 9, 2026 | Vasanthavada MadhavChief Commercial Officer · O | ▼ Sale | 9,620 | $5.36 | $52K | -3.1% | 2 tranches |
| Jun 9, 2026 | Seshadri VishwasChief Executive Officer · O·D | ▼ Sale | 56,344 | $5.36 | $302K | -3.9% | 2 tranches |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ABEO feed.